Merck opens €300m South Korea plant for regional biopharmaMembers
The 44,500-square-meter Daejeon facility produces dry cell culture media and process liquids to cut lead times for contract…
Company watch
All companies →Kolon Global
Every EAB briefing that touches Kolon Global — capital spending, plants, M&A, earnings and policy exposure. 1 briefing.
- First seen
- November 1, 2026
- Latest
- November 1, 2026
- With a linked document
- 1 of 1
- Named as exposed
- 1
- Desks
- Analysis (1)